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A case of multifocal EBV associated gastric carcinoma with focal squamous differentiation
Editor, Uncommon histologic variants represent approximately 5% of gastric carcinomas and include squamous carcinoma (SCC) and gastric carcinoma with lymphoid stroma (GCLS). Here, we report a rare case of GCLS with focal squamous differentiation.
A 58-year-old man complained of several occurrences of hematemesis and melena for three days. Gastric endoscopy disclosed an ulcerative lesion with oozing bleeding in the posterior wall of the high body and an ulcer scar-like lesion in the angle along the side of less curvature. Endoscopic biopsy was performed and the lesions were diagnosed as poorly differentiated adenocarcinomas. Subsequently, he underwent total gastrectomy and adjacent lymphadenectomy. On gross examination, the resected stomach showed two separate lesions of a slightly depressed EGC IIb lesion (1.1 × 1.1 × 0.7 cm) in the angle along the less curvature side and a shallow ulcerative lesion EGC type IIc (3 × 2 × 0.3 cm) in the posterior wall of high body [ Figure 1a and b].
Histologically, the first tumor consisted of two components [ Figure 2a and b]. One component was GCLS accounting for 85% of the total neoplasm and extended up to the deep submucosa (SM3). The tumor cells had eosinophilic cytoplasm and enlarged nuclei with prominent nucleoli and vesicular chromatin with moderately or poorly differentiated tubular structures. Marked infiltration of lymphocytes was observed in the stromal background [ Figure 2a ]. The other component was SCC which occupied 15% of the total neoplasm and was mainly located in superficial portion of the tumor. Carcinoma with lymphoid stroma (lymphoepithelioma) was primarily described in the nasopharynx. Although similar histologic features have been described in many other organs, Epstein-Barr virus (EBV) is frequently found in the carcinomas arising in the stomach, lung, thymus, and salivary gland. GCLS, constituting approximately 1-4% of all gastric carcinomas, tends to occur in old age with a male predominance and arises in the cardia or middle portion of the stomach. [1] Gastric SCC is an extremely rare malignancy with an incidence of 0.04-0.07%. [2] The prognosis of gastric SCC is probably less favorable than that of adenocarcinoma due to its higher frequency of lymphovascular and serosal invasions.
Our case is unique due to the rare histological combination with aggressive prognostic behavior; multiple metastases in the dissected lymph nodes by the GCLS component despite early T stage and early recurrence of the cancer (12 months) causing patient death (25 months) after surgery.
Although the pathogenesis of the coexistence of two components is unknown, there might be three possible origins of both components in the stomach. First, the two tumors seem to collide and form one mass. Second, the two tumors originated from a multipotential precursor cell able to differentiate along the lines of EBV-associated adenocarcinoma and the other demonstrated squamous differentiation. Third, squamous metaplasia or squamous differentiation occurred in a pre-existing GCLS. Considering the presence of a transition area between the two components and the superficial location of the squamous component, we suggest the last possibility. The role of EBV in the carcinogenesis of SCC is unclear in the stomach. Interestingly, Takita et al. detected EBV in surgical specimens of the tumor by polymerase chain reaction and proposed that EBV infection may be involved in the pathogenesis of certain cases of gastric SCC. [3] Programmed death ligand 1 (PD-L1), which is a cell surface protein of B7 family, serves as negative regulators of T cell-mediated immunity. High PD-L1 expression in tumor cells has been suggested to be an important immune evasion mechanism. Some studies have confirmed the high expression of PD-L1 in EBV-associated malignancies, including specific subtypes of lymphomas, nasopharyngeal carcinoma, and EBV-associated gastric carcinoma. [4] In gastric cancer, it has been reported that high PD-L1 expression is correlated with aggressive clinicopathological features and poor prognosis. [5] Interestingly, in the present case, PD-L1 was only expressed in the squamous component. The prognostic significance of PD-L1 expression in our case is uncertain because the metastatic tumor was entirely composed of carcinoma with lymphoid stroma. We reported a rare case of multifocal GCLSs with focal squamous differentiation with an aggressive behavior. Clinicians and pathologists should keep in mind that such a tumor may occur in the stomach, and further studies are necessary to define the pathogenesis and biological behavior.
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